Literature DB >> 27974084

Insight, self-stigma and psychosocial outcomes in Schizophrenia: a structural equation modelling approach.

Y-J Lien1, H-A Chang2, Y-C Kao3, N-S Tzeng2, C-W Lu4, C-H Loh5.   

Abstract

AIMS: Poor insight is prevalent in patients with schizophrenia and has been associated with acute illness severity, medication non-adherence and poor treatment outcomes. Paradoxically, high insight has been associated with various undesirable outcomes, including low self-esteem, depression and low subjective quality of life (QoL) in patients with schizophrenia. Despite the growing body of studies conducted in Western countries supporting the pernicious effects of improved insight in psychosis, which bases on the level of self-stigma, the effects are unclear in non-Western societies. The current study examined the role of self-stigma in the relationship between insight and psychosocial outcomes in a Chinese population.
METHODS: A total of 170 outpatients with schizophrenia spectrum disorders were recruited from two general university hospitals. Sociodemographic data and clinical variables were recorded and self-report scales were employed to measure self-stigma, depression, insight, self-esteem and subjective QoL. Structural equation modelling (SEM) was used to analyse the cross-sectional data.
RESULTS: High levels of self-stigma were reported by 39% of the participants (n = 67). The influences of insight, self-stigma, self-esteem and depression on subjective QoL were confirmed by the SEM results. Our model with the closest fit to the data (χ 2 = 33.28; df = 20; p = 0.03; χ 2/df = 1.66; CFI = 0.98; TLI = 0.97; RMSEA = 0.06) demonstrated that self-stigma might fully mediate the association of insight with low self-esteem, depression and poor subjective QoL. High insight into illness contributed to self-stigma, which caused low self-esteem and depression and, consequently, low QoL. Notably, insight did not directly affect self-esteem, depression or QoL. Furthermore, the association of insight with poor psychosocial outcomes was not moderated by self-stigma.
CONCLUSIONS: Our findings support the mediating model of insight relevant to the poor psychosocial outcomes of individuals diagnosed with schizophrenia in non-Western societies, in which self-stigma plays a pivotal role. These findings elucidate the direct and indirect effects of insight on psychosocial outcomes and imply that identifying and correcting self-stigma in people with schizophrenia could be beneficial. Additional studies are required to identify whether several other neurocognitive or psychosocial variables mediate or moderate the association of insight with self-esteem, depression and QoL in patients with schizophrenia. Studies with detailed longitudinal assessments are necessary to confirm our findings.

Entities:  

Keywords:  Insight; mediation; moderation; quality of life; schizophrenia; self-stigma

Mesh:

Year:  2016        PMID: 27974084      PMCID: PMC6998951          DOI: 10.1017/S2045796016000950

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  49 in total

1.  Self-stigma, empowerment and perceived discrimination among people with schizophrenia in 14 European countries: the GAMIAN-Europe study.

Authors:  Elaine Brohan; Rodney Elgie; Norman Sartorius; Graham Thornicroft
Journal:  Schizophr Res       Date:  2010-03-26       Impact factor: 4.939

2.  Theory of mind and unawareness of illness in schizophrenia: is poor insight a mentalizing deficit?

Authors:  Emre Bora; Gulsah Sehitoglu; Mustafa Aslier; Ihsan Atabay; Baybars Veznedaroglu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-14       Impact factor: 5.270

3.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.

Authors:  R M Baron; D A Kenny
Journal:  J Pers Soc Psychol       Date:  1986-12

4.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

5.  Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients.

Authors:  A T Beck; R A Steer; R Ball; W Ranieri
Journal:  J Pers Assess       Date:  1996-12

6.  The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life.

Authors:  A Karow; F-G Pajonk; J Reimer; F Hirdes; C Osterwald; D Naber; S Moritz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

7.  Parents of adolescents with psychiatric disorders: insight into the disorder, self-stigma and parental stress.

Authors:  Ilanit Hasson-Ohayon; Rivka Tuval-Mashiach; Mayad Morag-Yaffe; Meyrav Gaziel; Lior Schapir; Gil Zalsman; Gal Shoval
Journal:  Compr Psychiatry       Date:  2014-03-21       Impact factor: 3.735

8.  Stigma resistance in patients with schizophrenia.

Authors:  Ingrid Sibitz; Annemarie Unger; Andreas Woppmann; Thomas Zidek; Michaela Amering
Journal:  Schizophr Bull       Date:  2009-06-01       Impact factor: 9.306

9.  The role of subjective illness beliefs and attitude toward recovery within the relationship of insight and depressive symptoms among people with schizophrenia spectrum disorders.

Authors:  Marialuisa Cavelti; Eva-Marina Beck; Sara Kvrgic; Joe Kossowsky; Roland Vauth
Journal:  J Clin Psychol       Date:  2012-02-13

Review 10.  Internalized Stigma of Mental Illness (ISMI) scale: a multinational review.

Authors:  Jennifer E Boyd; Emerald P Adler; Poorni G Otilingam; Townley Peters
Journal:  Compr Psychiatry       Date:  2013-09-21       Impact factor: 3.735

View more
  8 in total

1.  Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments.

Authors:  Paul H Lysaker; Michelle L Pattison; Bethany L Leonhardt; Scott Phelps; Jenifer L Vohs
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

2.  The Mental Health of Patients With Psychotic Disorder From a Positive, Multidimensional and Recovery Perspective.

Authors:  Miriam Broncano-Bolzoni; Mònica González-Carrasco; Dolors Juvinyà-Canal; MTeresa Lluch-Canut
Journal:  Front Psychol       Date:  2022-07-04

3.  Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centers.

Authors:  Hélène Verdoux; Clélia Quiles; Laura Bon; Isabelle Chéreau-Boudet; Julien Dubreucq; Emilie Legros-Lafarge; Nathalie Guillard-Bouhet; Catherine Massoubre; Julien Plasse; Nicolas Franck
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-10       Impact factor: 5.270

4.  Self-stigma in Serious Mental Illness: A Systematic Review of Frequency, Correlates, and Consequences.

Authors:  Julien Dubreucq; Julien Plasse; Nicolas Franck
Journal:  Schizophr Bull       Date:  2021-08-21       Impact factor: 9.306

5.  Self-Stigma and Treatment Effectiveness in Patients with SSRI Non-Responsive Obsessive-Compulsive Disorder.

Authors:  Marie Ociskova; Jan Prasko; Jakub Vanek; Michaela Holubova; Frantisek Hodny; Klara Latalova; Krystof Kantor; Vlastimil Nesnidal
Journal:  Psychol Res Behav Manag       Date:  2021-02-05

6.  Mediation of the stigma in the influence of negative symptomatology over recovery in psychosis.

Authors:  Nuria Ordóñez-Camblor; Mercedes Paino; Eduardo Fonseca-Pedrero; Juan Pablo Pizarro-Ruiz
Journal:  Int J Clin Health Psychol       Date:  2021-02-01

7.  Prevalence and correlates of self-stigma in Post-Traumatic Stress Disorder (PTSD).

Authors:  Catrin Lewis; Stan Zammit; Ian Jones; Jonathan I Bisson
Journal:  Eur J Psychotraumatol       Date:  2022-07-22

8.  Relationship of subjective quality of life with symptomatology, neurocognition and psychosocial functioning in first-episode psychosis: a structural equation modelling approach.

Authors:  Sandra Chi Yiu Wong; Wing Chung Chang; Christy Lai Ming Hui; Sherry Kit Wa Chan; Edwin Ho Ming Lee; Yi Nam Suen; Eric Yu Hai Chen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-07-25       Impact factor: 5.270

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.